Immvirx

Developer of immunotherapy for cancer treatment

placeNew Lambton, New South Wales, Australia calendar_todayFounded 2019 groups16 employees language immvirx.com

Social engagement

Social engagement: 1.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include One Ventures, Acorn Capital.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

20 Mar 2026
Event
NWR Communications Virtual Healthcare Conference
17 Mar 2026
Event
AACR Annual Meeting 2026
26 Nov 2025
Event
Bell Potter Securities Healthcare Conference
Coming soon